Date | Time | Source | Announcement |
---|---|---|---|
09 Feb 2004 | 07:00 AM | Clinical Trial Update | |
09 Feb 2004 | 07:00 AM | 1st Quarter Results | |
30 Jan 2004 | 01:18 PM | Result of AGM | |
30 Jan 2004 | 12:30 PM | AGM Statement | |
27 Jan 2004 | 04:33 PM | Holding(s) in Company | |
20 Jan 2004 | 07:00 AM | Re Agreement | |
20 Jan 2004 | 07:00 AM | Re Agreement | |
12 Jan 2004 | 12:00 PM | Clinical Trials Update | |
24 Dec 2003 | 07:00 AM | Re Amgen Collaboration | |
18 Dec 2003 | 04:34 PM | Holding(s) in Company | |
12 Dec 2003 | 04:57 PM | Director Shareholding | |
05 Dec 2003 | 10:57 AM | Doc re. Form 20-F | |
24 Nov 2003 | 03:27 PM | Director Shareholding | |
17 Nov 2003 | 07:00 AM | Final Results | |
14 Nov 2003 | 02:28 PM | Holding(s) in Company | |
24 Oct 2003 | 05:37 PM | Holding(s) in Company | |
21 Oct 2003 | 03:04 PM | Notice of Results | |
20 Oct 2003 | 01:08 PM | Result of EGM | |
16 Oct 2003 | 05:36 PM | Document Posted | |
14 Oct 2003 | 03:30 PM | Re Humira Royalties | |
10 Oct 2003 | 10:17 AM | Holding(s) in Company | |
22 Sep 2003 | 07:00 AM | Re: Licencing Agreement | |
22 Sep 2003 | 07:00 AM | Re Alliance | |
17 Sep 2003 | 07:00 AM | Analyst Site Visit | |
11 Sep 2003 | 09:15 AM | EU approval of Humira | |
08 Sep 2003 | 02:54 PM | Holding(s) in Company | |
03 Sep 2003 | 07:07 AM | CAT Micromet Agreement | |
03 Sep 2003 | 07:02 AM | CAT Micromet Enzon Agreement | |
03 Sep 2003 | 07:01 AM | 3rd Quarter Results | |
18 Aug 2003 | 05:19 PM | Holding(s) in Company | |
29 Jul 2003 | 04:34 PM | Notice of Results | |
11 Jul 2003 | 09:30 AM | Trail-R2 Progress | |
23 Jun 2003 | 10:13 AM | Directorate Change | |
17 Jun 2003 | 02:00 PM | CAT Clinical Trial Update | |
30 May 2003 | 10:30 AM | Research Update | |
29 May 2003 | 03:16 PM | Director Shareholding | |
23 May 2003 | 03:06 PM | HUMIRA Update | |
19 May 2003 | 07:00 AM | Interim Results | |
22 Apr 2003 | 04:05 PM | Notice of Results | |
22 Apr 2003 | 02:02 PM | Holding(s) in Company | |
14 Apr 2003 | 12:20 PM | Director Shareholding | |
11 Apr 2003 | 12:08 PM | Director Shareholding | |
09 Apr 2003 | 11:55 AM | Holding(s) in Company | |
01 Apr 2003 | 10:07 AM | Holding(s) in Company | |
31 Mar 2003 | 04:37 PM | Price Monitoring Extension | |
26 Mar 2003 | 07:01 AM | CAT- Humira Royalties | |
24 Mar 2003 | 07:01 AM | Offer Update | |
19 Mar 2003 | 11:19 AM | CAT Reports HGS Progress | |
11 Mar 2003 | 01:50 PM | Result of EGM | |
04 Mar 2003 | 11:34 AM | Holding(s) in Company |
CATCo Reinsurance Opportunities Fund Ltd. is a closed-ended mutual fund company. The Company is organized as a feeder fund to invest substantially all its assets in Markel CATCo Diversified Fund. Headquartered in Bermuda, CATCo is listed in London under the ticker CAT as well as the Bermuda Stock Exchange.
CAT share price listed at 1USD in 2010.